Interview with NEULAND
We were interviewed by the KIT magazine “NEULAND” about our startup Metis Neurotec. In the magazine you can now read what makes our startup so special and which approaches we envision in our treatment concept
News
We were interviewed by the KIT magazine “NEULAND” about our startup Metis Neurotec. In the magazine you can now read what makes our startup so special and which approaches we envision in our treatment concept
Worldwide, only 20-50% of all dementia cases are detected. Yet almost 90% of all physicians and patients surveyed call for early diagnosis in order to be able to respond to associated changes in care and
On October 20, we had the opportunity to present our progress since the beginning of 2021 to reviewers of the Helmholtz Enterprise Program as part of our interim evaluation. We presented our achievements and plans
At the DemoDay 2021 of BadenCampus we were honored with the audience award for our Startup Pitch on November 25, 2021. Our prize was sponsored by BANSBACH GmbH. We presented our startup Metis Neurotec in
We are one of the top 8 startups in this year’s DemoDay 2021, and now we will pitch again for the final title in front of the BadenCampus jury on 11/25. DemoDay 2021 is part
This year we successfully participated as a team at HackZurich (24.09. – 26.09.21). From a total of 155 projects, we were among the top 25 and thus in the finals. Briefly about HackZurich: “Founded in
“AHEAD is the central platform between the Fraunhofer-Gesellschaft and the national and international entrepreneurship ecosystems. As one of Europe’s premier technology transfer programs, we invest our passion for science into a new generation of deep
METIS Neurotec
Together against neurological diseases.
METIS was called into existence by funding from the Helmholtz Association in 2021.
Located in Karlsruhe, Germany, METIS aims to transfer deep tech to the field of dementia treatment and digital healthcare.